Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susana M Campos

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Breast Cancer Research and Treatment|March 17, 2005
Evolving treatment approaches for early breast cancerSusana M Campos
The Oncologist|March 30, 2004
Aromatase inhibitors for breast cancer in postmenopausal womenSusana M Campos
Cancer Investigation|October 15, 2008
Anti-epidermal growth factor receptor strategies for advanced breast cancerSusana M Campos
Journal of Oncology|January 14, 2010
A current review of targeted therapeutics for ovarian cancerSusana M Campos, Sue Ghosh
Hematology/Oncology Clinics of North America|April 24, 2012
Antimitotic inhibitorsSusana M Campos, Don S Dizon
Oncology|May 22, 2003
Hormonal therapy in postmenopausal women with breast cancerSusana M Campos, Eric P Winer
CA: a Cancer Journal for Clinicians|December 9, 2025
Maintenance therapy after first-line therapy for ovarian cancer: Quantitative effectivenessSusana M Campos, Jessica DiSilvestro, Stephanie V Blank
Journal of the National Comprehensive Cancer Network : JNCCN|December 1, 2005
Benefits associated with an early hemoglobin response to epoetin alfa therapy in the treatment of chemotherapy-related anemiaSusana M Campos, Mei Sheng Duh, Patrick Lefebvre, et al.
Gynecologic Oncology|February 28, 2012
Bevacizumab rechallenge after first line maintenance bevacizumabPanagiotis A Konstantinopoulos, Suzanne T Berlin, Susana M Campos, et al.
Gynecologic Oncology|August 14, 2013
Pushing the bar in treatment of cervical cancer: what can comprehensive cancer centers do on their own?Don S Dizon, Allison J Ambrosio, Colleen Feltmate, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Breast Cancer Research and Treatment|March 17, 2005
Evolving treatment approaches for early breast cancerSusana M Campos
The Oncologist|March 30, 2004
Aromatase inhibitors for breast cancer in postmenopausal womenSusana M Campos
Cancer Investigation|October 15, 2008
Anti-epidermal growth factor receptor strategies for advanced breast cancerSusana M Campos
Journal of Oncology|January 14, 2010
A current review of targeted therapeutics for ovarian cancerSusana M Campos, Sue Ghosh
Hematology/Oncology Clinics of North America|April 24, 2012
Antimitotic inhibitorsSusana M Campos, Don S Dizon
Oncology|May 22, 2003
Hormonal therapy in postmenopausal women with breast cancerSusana M Campos, Eric P Winer
CA: a Cancer Journal for Clinicians|December 9, 2025
Maintenance therapy after first-line therapy for ovarian cancer: Quantitative effectivenessSusana M Campos, Jessica DiSilvestro, Stephanie V Blank
Journal of the National Comprehensive Cancer Network : JNCCN|December 1, 2005
Benefits associated with an early hemoglobin response to epoetin alfa therapy in the treatment of chemotherapy-related anemiaSusana M Campos, Mei Sheng Duh, Patrick Lefebvre, et al.
Gynecologic Oncology|February 28, 2012
Bevacizumab rechallenge after first line maintenance bevacizumabPanagiotis A Konstantinopoulos, Suzanne T Berlin, Susana M Campos, et al.
Gynecologic Oncology|August 14, 2013
Pushing the bar in treatment of cervical cancer: what can comprehensive cancer centers do on their own?Don S Dizon, Allison J Ambrosio, Colleen Feltmate, et al.
Pageof 6